weitere Publikationen in der AG Rimmelzwaan

Prof. Dr. Guus Rimmelzwaan

Petry, M., Palus, M., Leitzen, E., Mitterreiter, J. G., Huang, B., Kröger, A., Verjans, G. M. G. M., Baumgärtner, W., Rimmelzwaan, G. F., Růžek, D., Osterhaus, A., & Prajeeth, C. K. (2021). Immunity to TBEV Related Flaviviruses with Reduced Pathogenicity Protects Mice from Disease but Not from TBEV Entry into the CNS. Vaccines: Open Access Journal, 9(3). https://doi.org/10.3390/vaccines9030196
Details anzeigen
van der Veldt, A. A. M., Oosting, S. F., Dingemans, A.-M. C., Fehrmann, R. S. N., GeurtsvanKessel, C., Jalving, M., Rimmelzwaan, G. F., Kvistborg, P., Blank, C. U., Smit, E. F., Lemmens, V. E. E. P., Hiltermann, T. J. N., Koopmans, M. P. G., Huckriede, A. L. W., Rots, N. Y., van Els, C. A. C. M., van Baarle, D., Haanen, J. B. A. G., & de Vries, E. G. E. (2021). COVID-19 vaccination: the VOICE for patients with cancer. Nature Medicine. https://doi.org/10.1038/s41591-021-01240-w
Details anzeigen
Saletti, G., Gerlach, T., Jansen, J. M., Molle, A., Elbahesh, H., Ludlow, M., Li, W., Bosch, B.-J., Osterhaus, A. D. M. E., & Rimmelzwaan, G. F. (2020). Older adults lack SARS CoV-2 cross-reactive T lymphocytes directed to human coronaviruses OC43 and NL63. Scientific Reports, 10: 21447. https://doi.org/10.1038/s41598-020-78506-9
Details anzeigen
Soilemetzidou, E.-S., De Bruin, E., Franz, M., Aschenborn, O. H. K., Rimmelzwaan, G. F., van Beek, R., Koopmans, M., Greenwood, A. D., & Czirják, G. Á. (2020). Diet may drive influenza A virus exposure in African mammals. The Journal of Infectious Diseases, 221(2), 175–182. https://doi.org/10.1093/infdis/jiz032
Details anzeigen
Westerhuis, B., Ten Hulscher, H., Jacobi, R., van Beek, J., Koopmans, M., Rimmelzwaan, G., Meijer, A., & van Binnendijk, R. (2020). Specific memory B cell response in humans upon infection with highly pathogenic H7N7 avian influenza virus. Scientific Reports, 10: 3152. https://doi.org/10.1038/s41598-020-60048-9
Details anzeigen
Wilken, L., & Rimmelzwaan, G. F. (2020). Adaptive Immunity to dengue virus: Slippery slope or solid ground for rational vaccine design? Pathogens, 9(6:470). https://doi.org/10.3390/pathogens9060470
Details anzeigen
de Vries, R. D., Nieuwkoop, N. J., Krammer, F., Hu, B., & Rimmelzwaan, G. F. (2020). Analysis of the vaccine-induced influenza B virus hemagglutinin-specific antibody dependent cellular cytotoxicity response. Virus Research: An International Journal of Molecular and Cellular Virology, 277: 197839. https://doi.org/10.1016/j.virusres.2019.197839
Details anzeigen
Elbahesh, H., Gerlach, T., Saletti, G., & Rimmelzwaan, G. F. (2019). Response modifiers: tweaking the immune response against influenza A virus. Frontiers in Immunology, 10: 809. https://doi.org/10.3389/fimmu.2019.00809
Details anzeigen
Elbahesh, H., Saletti, G., Gerlach, T., & Rimmelzwaan, G. F. (2019). Broadly protective influenza vaccines: design and production platforms. Current Opinion in Virology, 34, 1–9. https://doi.org/10.1016/j.coviro.2018.11.005
Details anzeigen
Gerlach, T., Elbahesh, H., Saletti, G., & Rimmelzwaan, G. F. (2019). Recombinant influenza A viruses as vaccine vectors. Expert Review of Vaccines, 18(4), 379–392. https://doi.org/10.1080/14760584.2019.1582338
Details anzeigen

Prajeeth K. Chittappen, PhD

Petry, M., Palus, M., Leitzen, E., Mitterreiter, J. G., Huang, B., Kröger, A., Verjans, G. M. G. M., Baumgärtner, W., Rimmelzwaan, G. F., Růžek, D., Osterhaus, A., & Prajeeth, C. K. (2021). Immunity to TBEV Related Flaviviruses with Reduced Pathogenicity Protects Mice from Disease but Not from TBEV Entry into the CNS. Vaccines: Open Access Journal, 9(3). https://doi.org/10.3390/vaccines9030196
Details anzeigen
Kronenberg, J., Pars, K., Brieskorn, M., Prajeeth, C. K., Heckers, S., Schwenkenbecher, P., Skripuletz, T., Pul, R., Pavlou, A., & Stangel, M. (2019). Fumaric acids directly influence gene expression of neuroprotective factors in rodent microglia. International Journal of Molecular Sciences, 20(2: 325). https://doi.org/10.3390/ijms20020325
Details anzeigen
Pars, K., Gingele, M., Kronenberg, J., Prajeeth, C. K., Skripuletz, T., Pul, R., Jacobs, R., Gudi, V., & Stangel, M. (2019). Fumaric acids do not directly influence gene expression of neuroprotective factors in highly purified rodent astrocytes. Brain Sciences, 9(9: 241). https://doi.org/10.3390/brainsci9090241
Details anzeigen

Husni Elhabesh, PhD

Di, H., Elbahesh, H., & Brinton, M. A. (2020). Characteristics of human OAS1 isoform proteins. Viruses, 12(2: 152). https://doi.org/10.3390/v12020152
Details anzeigen
Saletti, G., Gerlach, T., Jansen, J. M., Molle, A., Elbahesh, H., Ludlow, M., Li, W., Bosch, B.-J., Osterhaus, A. D. M. E., & Rimmelzwaan, G. F. (2020). Older adults lack SARS CoV-2 cross-reactive T lymphocytes directed to human coronaviruses OC43 and NL63. Scientific Reports, 10: 21447. https://doi.org/10.1038/s41598-020-78506-9
Details anzeigen
Bergmann, S., & Elbahesh, H. (2019). Targeting the proviral host kinase, FAK, limits influenza a virus pathogenesis and NFkB-regulated pro-inflammatory responses. Virology, 534, 54–63. https://doi.org/10.1016/j.virol.2019.05.020
Details anzeigen
Elbahesh, H., Gerlach, T., Saletti, G., & Rimmelzwaan, G. F. (2019). Response modifiers: tweaking the immune response against influenza A virus. Frontiers in Immunology, 10: 809. https://doi.org/10.3389/fimmu.2019.00809
Details anzeigen
Elbahesh, H., Saletti, G., Gerlach, T., & Rimmelzwaan, G. F. (2019). Broadly protective influenza vaccines: design and production platforms. Current Opinion in Virology, 34, 1–9. https://doi.org/10.1016/j.coviro.2018.11.005
Details anzeigen
Gerlach, T., Elbahesh, H., Saletti, G., & Rimmelzwaan, G. F. (2019). Recombinant influenza A viruses as vaccine vectors. Expert Review of Vaccines, 18(4), 379–392. https://doi.org/10.1080/14760584.2019.1582338
Details anzeigen
Jansen, J. M., Gerlach, T., Elbahesh, H., Rimmelzwaan, G. F., & Saletti, G. (2019). Influenza virus-specific CD4+ and CD8+ T cell-mediated immunity induced by infection and vaccination. Journal of Clinical Virology, 119, 44–52. https://doi.org/10.1016/j.jcv.2019.08.009
Details anzeigen
Meineke, R., Rimmelzwaan, G. F., & Elbahesh, H. (2019). Influenza virus infections and cellular kinases. Viruses, 11(2: 171). https://doi.org/10.3390/v11020171
Details anzeigen
Meineke, R., Rimmelzwaan, G. F., & Elbahesh, H. (2019). In vitro analysis of specific kinases on Influenza A virus infection. In 12th Graduate School Days: 29/30 November 2019 / Stiftung Tierärztliche Hochschule Hannover (p. Zoo P 09). https://elib.tiho-hannover.de/receive/tiho_mods_00003571
Details anzeigen